Amphastar Pharmaceuticals, Inc. Amortization of Intangible Assets in USD from 2012 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2012 to Q1 2025.
  • Amphastar Pharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending March 31, 2025 was $6.24M, a 1.18% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2024 was $24.7M, a 92.7% increase from 2023.
  • Amphastar Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2023 was $12.8M, a 1245% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2022 was $954K, a 10.9% decline from 2021.
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)

Amphastar Pharmaceuticals, Inc. Quarterly Amortization of Intangible Assets (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $6.24M +$73K +1.18% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q1 2024 $6.17M +$5.93M +2459% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q1 2023 $241K -$111K -31.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $352K +$76K +27.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $276K +$18K +6.98% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $258K -$12K -4.44% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $270K -$459K -63% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $729K +$8K +1.11% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $721K +$240K +49.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $481K $0 0% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q1 2015 $481K +$6K +1.26% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q1 2014 $475K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14

Amphastar Pharmaceuticals, Inc. Annual Amortization of Intangible Assets (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $24.7M +$11.9M +92.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-03
2023 $12.8M +$11.9M +1245% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-03
2022 $954K -$117K -10.9% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-03
2021 $1.07M +$35K +3.38% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $1.04M -$1K -0.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $1.04M -$950K -47.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 $1.99M -$869K -30.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 $2.86M +$339K +13.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $2.52M +$579K +29.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 $1.94M +$18K +0.94% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 $1.92M +$13K +0.68% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 $1.91M +$67K +3.64% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $1.84M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.